Germany's AquaNab secures funding for feed-delivered nanoantibody treatment targeting sea lice

13 Aug 2026
Germany's AquaNab secures funding for feed-delivered nanoantibody treatment targeting sea lice

Sea lice cost global aquaculture an estimated US$4 billion a year, and the alpaca-derived platform is designed to extend to other species and diseases.

Share:LinkedInX